Metastatic Uveal Melanoma Terminated Phase 2 Trials for Aldesleukin (DB00041)

Also known as: Metastatic Malignant Uveal Melanoma / Metastatic Uveal Melanoma (UM) / Uveal Melanoma, Metastatic / Melanoma, Uveal Metastatic

IndicationStatusPhase
DBCOND0051900 (Metastatic Uveal Melanoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01814046Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular MelanomaTreatment